Rigel Pharmaceuticals Inc. (RIGL)
NASDAQ: Health Care
$7.43
-0.12 | -1.59%
-0.12 | -1.59%
Today's Range:
7.43 -
7.61
RIGL Avg. Daily Volume:
303,100
05/30/12 - 9:40 AM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 7.55 |
| 52 Week High | 10.60 |
| 52 Week Low | 6.57 |
| Avg. Daily Vol. (Mil) | 0.30 |
| Beta (3 year) | 0.82 |
| Share Related Items | |
| Mkt Cap (Mil) | 539.48 |
| Shares Out (Mil) | 71.45 |
| Float (Mil) | 61.75 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 27.00 |
| Current Ratio | 28.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 98.09 |
| Price/Book | 2.49 |
| Price/Cash Flow | -6.30 |
| Per Share Data | |
| Earnings | -1.31 |
| Sales | 0.08 |
| Book Value | 3.03 |
| Cash Flow | -1.21 |
| Business Summary | |
|---|---|
| Rigel Pharmaceuticals, Inc is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. | |
| General Information | |
| 1180 Veterans Boulevard
South San Francisc, CA 94080 |
|
| www.rigel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 153 | |
| CEO: James M. Gower | |
| Short Interest | |
| Current Month (Mil) | 4.69 |
| Previous Month (Mil) | 4.33 |
| Short Interest Ratio (Days) | 14.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -37.80 |
| Return on Investments | -40.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,452.56 | 1,317.01 | 2,833.76 | 16.49 |
Oil *
104.06
|
|
DOWN
128.13 |
DOWN
15.41 |
DOWN
37.23 |
DOWN
0.82 |
10 Yr
1.65%
SPDR Gold
149.20
|
|
-1.02%
|
-1.16%
|
-1.30%
|
-4.74%
|
Data delayed 20 minutes |
Connect with TheStreet